OBJECTIVE: Elevated inflammatory markers are associated with alterations in fetal development and adverse birth outcomes. Adequate sleep may be important for regulating inflammatory processes during pregnancy. The purpose of this analysis was to evaluate associations between inflammatory markers and self-reported sleep duration in pregnant women. STUDY DESIGN: Of 744 pregnant women enrolled in a multi-site prospective cohort study, 694 completed a survey on sleep quality and provided a serum sample between 12-20 weeks gestation. Sleep quality was evaluated using the validated Pittsburgh Sleep Quality Index, which includes a question on average hours of sleep per night. Levels of inflammatory markers, including TNFa, CRP, IL6, and IL10, were measured in maternal serum and log transformed. A ratio of IL6:IL10 was calculated as an indicator of pro-inflammatory and anti-inflammatory balance. Multivariable linear regression was used to evaluate the associations between each of the inflammatory markers and self-reported hours of sleep per night. RESULTS: Women reported an average of 6.9 hours of sleep per night (standard deviation: 1.6). In models adjusted for maternal age, race/ethnicity, education, income, BMI, marital status, smoking, and gestational age at assessment, a one-hour decrease in average amount of sleep per night was associated with increases in 
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OBJECTIVE:
The AFE foundation in collaboration with Baylor College of Medicine has established an international AFE registry, using recently published diagnostic criteria for research reporting (Clark SL,2016 AJOG) . Given the theory of potential placental or fetal debris entering maternal circulation as a cause of AFE, we sought to investigate the relationship between abnormal placentation and occurrence of AFE. STUDY DESIGN: Charts of patients enrolled in the AFE registry between 2013 and 2017 were abstracted and women were classified as having AFE, unlikely to have an AFE, or indeterminate. Indeterminate cases were defined as those with incomplete records, or whose diagnosis remained uncertain after review. RESULTS: Of 145 currently enrolled patients, 115 had records available for review. Fifty-nine percent (68/115) were determined to have suffered an AFE, while 23% (26/115) were probable non-AFE, and 18% (21/115) were indeterminate. Seven percent (5/68) of women with an AFE had a placenta previa during the index pregnancy, compared to the established historical prevalence of 5 per 1,000 ajog.org Poster Session I Supplement to JANUARY 2019 American Journal of Obstetrics & Gynecology S101 births (0.5%). This represents a 15-fold increase in the prevalence of placenta previa in women with AFE. CONCLUSION: Administrative databases proposed various risk factors for AFE, but are hampered by misdiagnoses in a substantial proportion of cases. In our study, using strict criteria for AFE diagnosis, we identified placenta previa as a risk factor. Our data suggests that abnormal placentation, vis-à-vis placenta previa, may be an independent risk factor in the pathophysiology of AFE. OBJECTIVE: To determine if an association exists between hypertension in adulthood and a history of adolescent birth. STUDY DESIGN: We conducted a cross-sectional study using nationally representative data from the National Health and Nutrition Examination Survey (NHANES) cycles 2005-2016. Analysis was limited to women age 20 or older who had experienced at least one live birth and were not currently pregnant (n¼9,584). Hypertensive status was defined either by self-report of prior diagnosis or by mean systolic blood pressure (SBP) 130 mm Hg and/or diastolic blood pressure (DBP) 80 mm Hg during NHANES examination. Analyses utilized Chi-square and two-sample t tests with p 0.05. Regression models with adjustment for covariates were utilized to estimate the association between adolescent birth and hypertension. RESULTS: In our sample, there were more women with hypertension among those with a history of adolescent birth compared to those without (57.7% vs. 53.1%, respectively). Adjusted for age and race/ ethnicity, the odds of hypertension in adulthood among women with a history of adolescent birth was 1.48 times the odds among women without a history of adolescent birth (95% CI: 1.28, 1.70). The ratio of family income to poverty threshold, parity, and pack-years of smoking did not significantly affect the model. Education and body mass index (BMI) were included in the adjusted model to test for mediation, and resulted in a partially attenuated magnitude of the association (OR 1.26; 95% CI: 1.09, 1.44). Upon stratification by BMI, the association between adolescent birth and hypertension was particularly strong in normal weight and obese women (Table 1) . CONCLUSION: In a nationally representative sample of women over age twenty with a history of live birth, we found a significant association between history of adolescent birth and hypertension in adulthood. The results suggest that despite differences in socioeconomic status and health indicators, women with a history of adolescent birth have increased risk of hypertension in adulthood as compared to women whose first birth occurred after adolescence. These findings should motivate increased support for primary prevention efforts for adolescent pregnancy, and alert providers to the need for early lifestyle interventions and increased screening in this population. OBJECTIVE: Conflicting data exist regarding outcomes of monochorionic (MC) twin deliveries. While some report higher risk of adverse neonatal outcomes, others do not. Yet, most of the data derives from retrospective studies, thus multiple confounders may have affected the results. Since the Twin Birth Study was a prospective, randomized trial, we aim to evaluate perinatal outcomes among MC twins in the TBS population. STUDY DESIGN: The TBS included women with a twin gestation at a gestational age of 34+0 to 38+6 weeks in which the first twin was in the vertex presentation at randomization. Women were then randomized to planned cesarean section (CS) or planned vaginal delivery (VD). For the purpose of this sub-analysis, we included all women with MC pregnancies. Women in the planned CS arm were compared to women in the planned VD arm. We also compared the neonatal outcomes of dichorionic twins (DC) with MC twins. RESULTS: Out of the 2588 women who were included in the original study, 670 (25.9%) had MC gestation, of which 324 (48.4%) were randomized to VD, and 346 (51.6%) to CS. No significant differences were found in maternal or obstetrical demographics between the groups, or in maternal outcomes. No differences were found in the subsequent analyses as well: twins A versus twins B, planned VD versus planned CS twin A, planned VD versus planned CS twin B and planned VD twin A versus twin B. In the planned CS arm, twins B had higher rate of Fetal/neonatal death or serious neonatal morbidity than twins A (3.2% vs. 1.2%, p¼0.03), yet after exclusion of 2 neonatal deaths and 3 stillbirths, no differences were found in perinatal outcomes (Table 1) .
In the comparison of MC to DC twins, MC twins B were less likely to have a 5-minutes Apgar score<7 than DC twins B. Additionally, both MC twins A and B were less likely than DC twins A and B to have cord blood pH<7.0, and assisted ventilation (Table 2) . CONCLUSION: These results provide reassurance regarding maternal and neonatal outcomes of deliveries of MC twins, and can be used in the consultation of women with MC twin pregnancy.
